Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Relationship between FDG uptake on PET, tumor histology, and Ki-67 proliferation index in patients with breast cancer

Guohua Shen, Shuang Hu and Anren Kuang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1492;
Guohua Shen
2Department of Nuclear Medicine West China Hospital of Sichuan University Chengdu China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuang Hu
1Chengdu China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anren Kuang
2Department of Nuclear Medicine West China Hospital of Sichuan University Chengdu China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1492

Objectives PET-CT, which is a molecular imaging tool, can be a useful technique for assessing tumor proliferation activity and predicting the malignant potential of certain tumors. Thus, we aimed to compare 18F-FDG uptake on PET/CT to tumor histologic features and Ki-67 proliferation index, and further investigate whether a correlation exists.

Methods Between January 2012 and December 2014, 43 patients (mean age, 47.6 years) with histologically confirmed breast cancer were recruited. They all underwent 18F-FDG PET/CT for initial staging before therapy. All cases were assigned to one of two groups according to the clinicopathological variables: age (≤45 years vs. >45 years), tumor size (≤2 cm vs. >2 cm), axillary nodal status (negative vs. positive metastasis), histological type (invasive ductal and invasive lobular), and the Ki-67 proliferation index (≤20 % vs. >20 %). The SUVmax measurements between groups were compared, and its correlations with tumor size and Ki-67 proliferation index were also assessed.

Results The mean size of the invasive tumors was 2.4±0.8 cm (range: 0.9-5.8 cm), and 21 patients had pT1 lesions (&#8804; 2 cm). In 19 patients positive axillary lymph nodes were detected. Thirty patients had low Ki-67 scores and 13 patients had high Ki-67 scores. In addition, the histological findings revealed invasive ductal carcinoma (IDC) in 35 patients and invasive lobular carcinoma (ILC) in eight patients. The mean SUVmax of the 43 tumors was 9.8±4.3 (range: 2.6-29.4). The mean SUVmax value for tumors >2 cm was higher than that of tumors &#8804;2 cm (11.2±4.5 vs. 8.5±2.4, p<0.05). The mean SUVmax for high Ki-67 subgroup (13.1±5.2) was higher than that for low Ki-67 subgroup (9.1±3.7, p<0.05). However, these factors including age, nodal status and histologic type did not show a significant relationship with SUVmax (Table 1). Based on Spearman correlation analysis, a positive correlation between 18F-FDG uptake (SUVmax) and Ki-67 (Spearman’s rho=0.87, P=0.004) as well as tumor size (Spearman’s rho=0.65, P=0.001) was observed (Figure 1). However, Ki-67 was not correlated with tumor size (Spearman’s rho=0.15, P=0.65).

Conclusions 18F-FDG uptake on PET/CT correlates significantly with Ki-67 proliferation index and tumor size in breast cancer. It has a potential value for identifying more aggressive behavior. This study was supported by National Natural Science Foundation of China (Grant No. 81471692).

View this table:
  • View inline
  • View popup

Table 1. Relationships between clinicopathological factors and SUVmax

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship between FDG uptake on PET, tumor histology, and Ki-67 proliferation index in patients with breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Relationship between FDG uptake on PET, tumor histology, and Ki-67 proliferation index in patients with breast cancer
Guohua Shen, Shuang Hu, Anren Kuang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1492;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Relationship between FDG uptake on PET, tumor histology, and Ki-67 proliferation index in patients with breast cancer
Guohua Shen, Shuang Hu, Anren Kuang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1492;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Clinical value of 68Ga-DOTATATE PET/CT in the evaluation of recurrent medullary thyroid cancer patients.
  • The diagnostic performance and added value of 18F-NaF PET/CT in the detection of bone metastases in patients with nasopharyngeal carcinoma
  • Prognostic value of pre-treatment 18F-FDG PET/CT volumetric parameters in patients with locally advanced larynx carcinoma.
Show more Oncology, Clinical Science Track

MTA I: Breast Cancer Posters

  • Correlation between 18F-FDG uptake on PET/CT and proliferation index in patients with breast cancer
  • Comparison of diagnostic performance of dbPET and WB-PET/CT in detection of breast cancer according to histological grade/histopathological classification
  • FDG PET/CT & Breast Cancer: Value of Fourth and Subsequent Post Therapy follow up scans for Patient Management
Show more MTA I: Breast Cancer Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire